SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 235 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,685 | -8.3% | 714 | 0.0% | 0.14% | -8.6% |
Q2 2023 | $21,463 | -17.0% | 714 | 0.0% | 0.15% | -16.5% |
Q1 2023 | $25,868 | -92.2% | 714 | -91.5% | 0.18% | +5966.7% |
Q4 2017 | $333,000 | -8.3% | 8,355 | -7.8% | 0.00% | -25.0% |
Q3 2017 | $363,000 | -12.5% | 9,064 | -5.9% | 0.00% | 0.0% |
Q2 2017 | $415,000 | +33.9% | 9,628 | -2.9% | 0.00% | +33.3% |
Q1 2017 | $310,000 | +1048.1% | 9,915 | +296.9% | 0.00% | – |
Q2 2014 | $27,000 | – | 2,498 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |